Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

BBB Foods Inc. Class A Common Shares (NY:TBBB)

25.82 -0.20 (-0.79%)
Streaming Delayed Price Updated: 9:49 AM EDT, Jul 21, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about BBB Foods Inc. Class A Common Shares

BBB Foods Stock In Focus After Grupo Santander Initiates Coverage Of ‘Fast-Growing’ Discount Grocery Chain: Retail’s Cautious
The company recently announced the closing of a successful public offering for 21 million of its class A common shares at a price of $28.25 per share. 
Via Stocktwits
3 Top Stocks for January 2025 and Beyond
Whether you want higher risk and higher reward, stability with a high yield, or international opportunity, we have a great stock idea for you. 
Via The Motley Fool
2 Incredible Growth Stocks to Buy in 2025 and Hold Forever
These two stocks have tons of potential. 
Via The Motley Fool
2 Top Stocks on My Radar for 2025
Want to outperform the market next year? These two stocks could help you do it. 
Via The Motley Fool
2 Smart Stocks Worth Buying Before December Ends
A big new winner and a discounted giant. 
Via The Motley Fool
Earnings Scheduled For November 25, 2024
Via Benzinga
Earnings Scheduled For May 7, 2025
Via Benzinga
Is This Fast-Growing Chain the Next Costco?
This concept has exploded with 2,772 locations across North America. And it's just getting started. 
Via The Motley Fool
Topics Initial Public Offering
Mexican Grocery Chain BBB Foods Lands Upgrade, But Retail Interest Remains Week A Year After NYSE Debut
BBB Foods operates about 2,800 Tiendas 3B stores and clocked $2.83 billion in sales last year. 
Via Stocktwits
Topics Initial Public Offering
Is Kroger a Stock to Recession-Proof Your Portfolio?
It may be riskier now than ever. Here's an alternative. 
Via The Motley Fool
2 Stocks I'd Buy Right Now, Even if a Recession Is Coming
The market has dropped quite a bit, and many experts see things getting worse. 
Via The Motley Fool
Topics Economy World Trade
Earnings Scheduled For April 9, 2025
Via Benzinga
2 Monster Stocks to Buy in October
We think these two stocks can deliver massive returns for long-term investors. 
Via The Motley Fool
TBBB Stock Earnings: BBB Foods Beats EPS, Beats Revenue for Q2 2024
TBBB stock results show that BBB Foods beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024. 
Via InvestorPlace
Nvidia's 10% Leap Propels Tech Indexes To Record Highs; Blue Chips, Small Caps Slip: What's Driving Markets Thursday?
Strong earnings and revenue guidance from Nvidia sparked a tech stock surge, with Nasdaq 100 and S&P 500 hitting record highs. 
Via Benzinga
Topics Stocks
e.l.f. Beauty Posts Upbeat Earnings, Joins Nvidia, LiveRamp Holdings, Borr Drilling And Other Big Stocks Moving Higher On Thursday
Via Benzinga
Stocks Falter, Metals Fall As Traders Turn Cautious Ahead Of Fed Minutes, Nvidia Earnings; First Solar Hits Record Highs: What's Driving Markets Wednesday?
Wall Street experienced a muted session on Wednesday morning as traders adopted a cautious stance ahead of the Federal Reserve meeting minutes release at 2 p.m. EDT and Nvidia Corp. 
Via Benzinga
Topics Economy
12 Consumer Staples Stocks Moving In Friday's Intraday Session
Via Benzinga
Top 5 Defensive Stocks That May Plunge This Quarter
As of March 25, 2024, five stocks in the consumer staples sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions. 
Via Benzinga
IPO Revival In 2024: Plaid, Chime, And Kim Kardashian's Skims Among Potential Market Movers
Market for IPOs expected to rebound in 2024 after inflation & interest rate rise hit new listings in 2022-23. 2023 saw 50% decrease in IPOs globally. 
Via Benzinga
Topics Economy Initial Public Offering
Gilead-Backed Kyverna Overshoots Raised IPO Expectations
Kyverna Therapeutics raised almost $320 million in its initial public offering, which was priced above the marketed range. Backed by Gilead Sciences, the company's offering was the second largest for a... 
Via Talk Markets
Topics Initial Public Offering
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.